News

226 to 235 of 95894 results

ANI Pharma acquires Vancocin assets from Shire

ANI Pharma acquires Vancocin assets from Shire

02-08-2014

US generic drugmaker ANI Pharmaceuticals says it has acquired the US rights for the antibiotic Vancocin…

ANI PharmaceuticalsAntibiotics and Infectious diseasesEli Lilly and CompanyGenericsGlycopeptide antibioticsIrelandMergers & AcquisitionsNew DrugShireUSAVancocinVancomycin HCl

Theraclone out-licenses HIV bNAbs to Gilead

Theraclone out-licenses HIV bNAbs to Gilead

01-08-2014

US privately-held drug developer Theraclone Sciences has entered into an agreement with biotech major…

Anti-viralsBiotechnologyBusiness FinanceGilead SciencesHIV/AIDSLicensingTheraclone SciencesUSA

Ziopharm and Solasia amend collaboration for darinaparsin

Ziopharm and Solasia amend collaboration for darinaparsin

01-08-2014

US drug developer Ziopharm Oncology and Japan’s Solasia Pharma, a developer of oncology pharmaceuticals…

darinaparsinGlobalLicensingOncologyPharmaceuticalSolasia PharmaZinaparZiopharm Oncology

French regulators push for huge cut in hypnotic benzodiazepine reimbursement

French regulators push for huge cut in hypnotic benzodiazepine reimbursement

01-08-2014

French regulators are attempting to discourage the over-consumption and misuse of hypnotic benzodiazepines…

diazepamFranceFrench governmentNeurologicalPharmaceuticalRegulation

This week’s pharma financial results in brief

This week’s pharma financial results in brief

01-08-2014

A whole host of pharma, biotech and generics companies released second quarter and first half results…

FinancialGlobal

UK aims to become world number one in DNA testing with new investment

UK aims to become world number one in DNA testing with new investment

01-08-2014

David Cameron, the UK Prime Minister, has announced a package of investment worth more than £300 million…

BiotechnologyDavid CameronGeneticsIlluminaMedical Research CouncilResearchUK

226 to 235 of 95894 results

Back to top